Advit Jewels IPO Set for Market Debut Today Amidst Promising GMP Indications of Strong Listing Gains!
Advit Jewels, a Jaipur-based handcrafted jewellery manufacturer, is poised for a significant stock market debut on the BSE and NSE this Wednesday, buoyed by strong investor enthusiasm reflected in its grey market performance. The company’s shares are currently trading at a grey market premium (GMP) of approximately Rs 50, or a 36% increase over the upper issue price of Rs 138. This premium suggests that the stock may list around Rs 188 per share, indicating potential gains for investors, albeit with the inherent uncertainty that grey market metrics introduce.
The overwhelming interest in Advit Jewels’ IPO, which saw subscriptions reach an impressive 212.63 times against 83.97 lakh shares available, underscores robust demand across investor demographics. Particularly notable is the Non-Institutional Investor (NII) category, which was subscribed 536.38 times, alongside Qualified Institutional Buyers (QIBs) at 174.98 times. Retail participation was also significant, with subscriptions hitting 95.30 times the allocated quota, highlighting a broad-based endorsement of the company’s growth prospects.
The IPO, valued at Rs 165.16 crore, consists solely of a fresh issue with no Offer for Sale (OFS) component, ensuring that the proceeds directly benefit Advit Jewels. The allocation of approximately Rs 65 crore for working capital and an equal amount for debt repayment aims to stabilize and fortify the company’s balance sheet. This strategic financial maneuver is expected to enhance operational flexibility and pave the way for future growth initiatives, thereby boosting the overall financial health and scalability of the business.
Advit Jewels, operating under the Rambhajo brand, maintains a significant presence in India’s flourishing jewellery sector, specializing in a blend of traditional and contemporary designs. The fully integrated manufacturing facility equipped with advanced technological tools facilitates comprehensive production in-house, ensuring rigorous quality control. With strong revenue and profitability figures reported for the nine-month period ending December 31, 2025, the company appears well-positioned to capitalize on its market debut, attracting investor confidence as it embarks on its next growth phase.
Source: The Economic Times
(Expert Note: This report was prepared by the Wealthova team.)